Status:
UNKNOWN
Antiviral Activity of Oral Probiotics
Lead Sponsor:
John Hale
Conditions:
Lower Respiratory Tract Infection
Upper Respiratory Tract Infection
Eligibility:
All Genders
18-80 years
Phase:
NA
Brief Summary
The aim of this study is to test saliva samples obtained from healthy human participants for anti-viral activity after they have consumed S. salivarius probiotic in a powder format.
Detailed Description
This is a randomized controlled open pilot study to evaluate saliva samples collected from participants following their consumption of powders containing the commercially marketed probiotic bacterium ...
Eligibility Criteria
Inclusion
- Inclusion criteria:
- In general good health 18 - 80 years of age.
- Practice good oral hygiene.
- Exclusion criteria:
- Have a history of autoimmune disease or are immunocompromised.
- Are on concurrent antibiotic therapy or regular antibiotic use within last 1 week
- History of allergy (e.g. dairy).
Exclusion
Key Trial Info
Start Date :
May 23 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
August 15 2022
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT05374070
Start Date
May 23 2022
End Date
August 15 2022
Last Update
May 13 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Blis Technologies Ltd
Dunedin, Otago, New Zealand, 9012